Cited by 16,003Global Cancer Incidence and ScreeningColorectal Cancer Screening and DetectionScience, Research, and Medicine

The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.

Cancer statistics, 2016

Open access

Siegel, Rebecca L., Miller, Kimberly D., Jemal, Ahmedin·2016·CA: A Cancer Journal for Clinicians

DOI 10.3322/caac.21332

Open this paper in CoChat — free account

Abstract

Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the National Cancer Institute (Surveillance, Epidemiology, and End Results [SEER] Program), the Centers for Disease Control and Prevention (National Program of Cancer Registries), and the North American Association of Central Cancer Registries. Mortality data were collected by the National Center for Health Statistics. In 2016, 1,685,210 new cancer cases and 595,690 cancer deaths are projected to occur in the United States. Overall cancer incidence trends (13 oldest SEER registries) are stable in women, but declining by 3.1% per year in men (from 2009‐2012), much of which is because of recent rapid declines in prostate cancer diagnoses. The cancer death rate has dropped by 23% since 1991, translating to more than 1.7 million deaths averted through 2012. Despite this progress, death rates are increasing for cancers of the liver, pancreas, and uterine corpus, and cancer is now the leading cause of death in 21 states, primarily due to exceptionally large reductions in death from heart disease. Among children and adolescents (aged birth‐19 years), brain cancer has surpassed leukemia as the leading cause of cancer death because of the dramatic therapeutic advances against leukemia. Accelerating progress against cancer requires both increased national investment in cancer research and the application of existing cancer control knowledge across all segments of the population. CA Cancer J Clin 2016;7–30. © 2015 American Cancer Society.

Integrity signals

Registry

Crossref · 10.3322/caac.21332

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,404
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
The Health consequences of smoking—50 years of progress : a report of the Surgeon General
Lushniak, B. D., Samet, J. M., Pechacek, T. F., Norman, L., & Taylor, P. A. (2014) · Cited by 4,990
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,810
Breast cancer statistics, 2019
Desantis, C. E., Ma, J., Gaudet, M. M., Newman, L. A., Miller, K. D., Sauer, A. G., Jemal, A., & Siegel, R. L. (2019) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21583 · Cited by 3,222
Self-citation
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L. D., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,456
Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
Edwards, B. K., Ward, E., Kohler, B. A., Eheman, C., Zauber, A. G., Anderson, R. N., Jemal, A., Schymura, M. J., Lansdorp‐Vogelaar, I., Seeff, L. C., et al. (2010) · Cancer · doi:10.1002/cncr.24760 · Cited by 2,002
Self-citation
Breast Cancer Statistics
Ma, J., & Jemal, A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5647-6_1 · Cited by 1,918
Self-citation
Cancer Disparities by Race/Ethnicity and Socioeconomic Status
Ward, E., Jemal, A., Cokkinides, V. E., Singh, G. K., Cardinez, C. J., Ghafoor, A., & Thun, M. J. (2004) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.2.78 · Cited by 1,796 · cited 1×
“prevention and early detection, timely diagnosis, and optimal treatment.(60,61) Even among Medicare-insured patients,”
BackgroundSelf-citation

Flagged first, then by citations

Show all 66 references

1 of the 66 references couldn’t be matched to a known paper.

Research works printed but not linked: 5

Copeland G, 2015, Cancer in North America: 2008‐2012
Copeland G, 2015, Cancer in North America: 2008‐2012. Vol 2. Registry‐Specific Cancer Incidence in the United States and Canada
World Health Organization, 2011, International Statistical Classification of Diseases and Related Health Problems. 10th Rev. Vols. I‐III
Surveillance Research Program, 2015, SEER*Stat Software
2015, Joinpoint Regression Program, Version 4.2.0.2

Sorted by citations

Items 401–500 of 1,071

MicroRNA: A novel target of curcumin in cancer therapy
Mirzaei, H., Masoudifar, A., Sahebkar, A., Zare, N., Sadri Nahand, J., Rashidi, B., Mehrabian, E., Mohammadi, M., Mirzaei, H. R., & Jaafari, M. R. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26055 · Cited by 236
Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies – A review
Al-Abd, A. M., Alamoudi, A. J., Abdel‐Naim, A. B., Neamatallah, T., & Ashour, O. M. (2017) · Journal of Advanced Research · doi:10.1016/j.jare.2017.06.006 · Cited by 202
Engineered Hydrogels in Cancer Therapy and Diagnosis
Sepantafar, M., Maheronnaghsh, R., Mohammadi, H., Radmanesh, F., Hasani‐Sadrabadi, M. M., Ebrahimi, M., & Baharvand, H. (2017) · Trends in biotechnology · doi:10.1016/j.tibtech.2017.06.015 · Cited by 198
Comprehensive landscape and future perspectives of circular RNAs in colorectal cancer
Long, F., Lin, Z., Li, L., Ma, M., Lu, Z., Jing, L., Li, X., & Lin, C. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01318-6 · Cited by 198
Association of Ablative Radiation Therapy With Survival Among Patients With Inoperable Pancreatic Cancer
Reyngold, M., O'Reilly, E. M., Varghese, A. M., Fiasconaro, M., Zinovoy, M. R., Romesser, P. B., Wu, A. J.-C., Hajj, C., Cuaron, J. J., Tuli, R., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.0057 · Cited by 198
Photoprotection: extending lessons learned from studying natural sunscreens to the design of artificial sunscreen constituents
Baker, L. A., Marchetti, B., Karsili, T. N. V., Stavros, V. G., & Ashfold, M. N. R. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00102a · Cited by 201
Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma
Sapir, E., Tao, Y., Schipper, M. J., Bazzi, L. A., Novelli, P. M., Devlin, P., Owen, D., Cuneo, K. C., Lawrence, T. S., Parikh, N. D., et al. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.09.001 · Cited by 194
Potentialities of selenium nanoparticles in biomedical science
Nayak, V., Singh, K. R., Singh, A. K., & Singh, R. P. (2021) · New Journal of Chemistry · doi:10.1039/d0nj05884j · Cited by 198
Fusobacterium nucleatum and cancer
Alon‐Maimon, T., Mandelboim, O., & Bachrach, G. (2022) · Periodontology 2000 · doi:10.1111/prd.12426 · Cited by 203
Cancer-associated fibroblasts: Origin, function, imaging, and therapeutic targeting
Rimal, R., Desai, P. B., Daware, R., Hosseinnejad, A., Prakash, J., Lammers, T., & Singh, S. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114504 · Cited by 210
Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence
Coutinho, I., Day, T. K., Tilley, W. D., & Selth, L. A. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0422 · Cited by 197
Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice
Kokolus, K. M., Zhang, Y., Sivik, J. M., Schmeck, C., Zhu, J., Repasky, E. A., Drabick, J. J., & Schell, T. D. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1405205 · Cited by 200
Phosphatidylserine: A cancer cell targeting biomarker
Sharma, B., & Kanwar, S. S. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.08.012 · Cited by 207
Fecal Clostridium symbiosum for Noninvasive Detection of Early and Advanced Colorectal Cancer: Test and Validation Studies
Xie, Y., Gao, Q., Cai, G. X., Sun, X. M., Zou, T.-H., Chen, H. M., Yu, S.-Y., Qiu, Y.-W., Gu, W.-Q., Chen, X. Y., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.10.005 · Cited by 195
Oncogenic Kras drives invasion and maintains metastases in colorectal cancer
Boutin, A. T., Liao, W.-T., Wang, M., Hwang, S. S., Karpinets, T. V., Cheung, H., Chu, G. C., Jiang, S., Hu, J., Chang, K., et al. (2017) · Genes & Development · doi:10.1101/gad.293449.116 · Cited by 195
Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer Surgery
Salazar, M. C., Rosen, J. E., Wang, Z., Arnold, B. N., Thomas, D. C., Herbst, R. S., Kim, A. W., Detterbeck, F. C., Blasberg, J. D., & Boffa, D. J. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5829 · Cited by 194
FDA Approval Summary: Atezolizumab or Pembrolizumab for the Treatment of Patients with Advanced Urothelial Carcinoma Ineligible for Cisplatin-Containing Chemotherapy
Suzman, D. L., Agrawal, S., Ning, Y. M., Maher, V. E., Fernandes, L. L., Karuri, S. W., Tang, S. W., Sridhara, R., Schroeder, J., Goldberg, K. B., et al. (2018) · The Oncologist · doi:10.1634/theoncologist.2018-0084 · Cited by 194
Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer
Ma, C. X., Bose, R., Gao, F., Freedman, R. A., Telli, M. L., Kimmick, G., Winer, E., Naughton, M., Goetz, M. P., Russell, C., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0900 · Cited by 193
A brief review of the management of platinum-resistant–platinum-refractory ovarian cancer
Oronsky, B. T., Ray, C. M., Spira, A. I., Trepel, J. B., Carter, C. A., & Cottrill, H. M. (2017) · Medical Oncology · doi:10.1007/s12032-017-0960-z · Cited by 193
Survival Rates After Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer
Cao, J., Yuan, P., Wang, Y., Xu, J., Yuan, X., Wang, Z., Lv, W., & Hu, J. (2018) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2018.01.032 · Cited by 192
The Global and Regional Survival Rate of Women With Breast Cancer: A Systematic Review and Meta-analysis
Maajani, K., Jalali, A., Alipour, S., Khodadost, M., Tohidinik, H. R., & Yazdani, K. (2019) · Clinical Breast Cancer · doi:10.1016/j.clbc.2019.01.006 · Cited by 192
A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy
Song, J., Shi, J., Dong, D., Fang, M., Zhong, W., Wang, K., Wu, N., Huang, Y., Liu, Z., Cheng, Y., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2507 · Cited by 188
Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling
Shen, M., Jiang, Y., Wei, Y., Ell, B. J., Sheng, X., Esposito, M., Kang, J., Hang, X., Zheng, H., Rowicki, M., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2018.11.016 · Cited by 203
Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects
Kamarudin, M. N. A., Sarker, M. M. R., Zhou, J., & Parhar, I. S. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1495-2 · Cited by 191
Metal–Organic Framework Composites for Theragnostics and Drug Delivery Applications
Osterrieth, J. W. M., & Fairen‐Jiménez, D. (2020) · Biotechnology Journal · doi:10.1002/biot.202000005 · Cited by 195
The immunopeptidomic landscape of ovarian carcinomas
Schuster, H., Peper-Gabriel, J. K., Bösmüller, H.-C., Roehle, K., Backert, L., Bilich, T., Ney, B., Loeffler, M. W., Kowalewski, D. J., Trautwein, N., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707658114 · Cited by 188
Testicular Cancer
Smith, Z. L., Werntz, R. P., & Eggener, S. E. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.10.003 · Cited by 190
Targeting regulatory T cells by curcumin: A potential for cancer immunotherapy
Shafabakhsh, R., Pourhanifeh, M. H., Mirzaei, H. R., Sahebkar, A., Asemi, Z., & Mirzaei, H. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104353 · Cited by 192
Efficient skin lesion segmentation using separable-Unet with stochastic weight averaging
Tang, P., Liang, Q., Yan, X., Xiang, S., Sun, W., Zhang, D., & Coppola, G. (2019) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2019.07.005 · Cited by 190
Icariin‐induced inhibition of SIRT6/NF‐κB triggers redox mediated apoptosis and enhances anti‐tumor immunity in triple‐negative breast cancer
Song, L., Chen, X., Mi, L., Liu, C., Zhu, S., Yang, T., Luo, X., Zhang, Q., Lu, H., & Liang, X. (2020) · Cancer Science · doi:10.1111/cas.14648 · Cited by 189
Potentialities of bioinspired metal and metal oxide nanoparticles in biomedical sciences
Singh, K. R., Nayak, V., Singh, J., Singh, A. K., & Singh, R. P. (2021) · RSC Advances · doi:10.1039/d1ra04273d · Cited by 193
Screening of colorectal cancer: present and future
Maida, M. F., Macaluso, F. S., Ianiro, G., Mangiola, F., Sinagra, E., Hold, G. L., Maida, C. D., Cammarota, G., Gasbarrini, A., & Scarpulla, G. (2017) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2017.1392243 · Cited by 192
Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett’s esophagus
Moinova, H., LaFramboise, T., Lutterbaugh, J., Chandar, A. K., Dumot, J. A., Faulx, A. L., Brock, W. E., Cabrera, O. D. L. C., Guda, K., Barnholtz‐Sloan, J. S., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aao5848 · Cited by 185
Myeloid‐Derived Suppressor Cell Membrane‐Coated Magnetic Nanoparticles for Cancer Theranostics by Inducing Macrophage Polarization and Synergizing Immunogenic Cell Death
Yu, G., Rao, L., Wu, H., Yang, L., Bu, L., Deng, W., Wu, L., Nan, X., Zhang, W., Zhao, X., et al. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201801389 · Cited by 190
WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer
Castagnoli, L., Cancila, V., Cordoba-Romero, S. L., Faraci, S., Talarico, G., Belmonte, B., Iorio, M. V., Milani, M., Volpari, T., Chiodoni, C., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0700-2 · Cited by 184
Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone
Lolli, C., Caffo, O., Scarpi, E., Aieta, M., Conteduca, V., Maines, F., Bianchi, E., Massari, F., Veccia, A., Chiurì, V. E., et al. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00376 · Cited by 188
Advances in Lipidomics for Cancer Biomarkers Discovery
Perrotti, F., Rosa, C., Cicalini, I., Sacchetta, P., Boccio, P. D., Genovesi, D., & Pieragostino, D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17121992 · Cited by 196
Immune checkpoint inhibitors and elderly people: A review
Daste, A., Domblides, C., Gross‐Goupil, M., Chakiba, C., Quivy, A., Cochin, V., de Monès, E., Larmonier, N., Soubeyran, P., & Ravaud, A. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.05.044 · Cited by 194
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for Anal Squamous Cell Cancers (Revised 2018)
Stewart, D. B., Gaertner, W. B., Glasgow, S. C., Herzig, D. O., Feingold, D. L., & Steele, S. R. (2018) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000001114 · Cited by 188
Cumulative Burden of Colorectal Cancer–Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer
Archambault, A. N., Su, Y., Jeon, J., Thomas, M., Lin, Y., Conti, D. V., Win, A. K., Sakoda, L. C., Lansdorp‐Vogelaar, I., Peterse, E. F. P., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.12.012 · Cited by 192
Exercise interventions for individuals with advanced cancer: A systematic review
Dittus, K. L., Gramling, R. E., & Ades, P. A. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.07.015 · Cited by 191
TMPRSS2–ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer
Kron, K. J., Murison, A. J., Zhou, S., Huang, V., Yamaguchi, T. N., Shiah, Y.-J., Fraser, M. E., van der Kwast, T., Boutros, P. C., Bristow, R. G., et al. (2017) · Nature Genetics · doi:10.1038/ng.3930 · Cited by 189
Lipid metabolism and lung cancer
Salvador, M. M., de Cedrón, M. G., Moreno‐Rubio, J., Martínez, S. F., Sánchez‐Martínez, R., Casado, E., de Molina, A. R., & Sereno, M. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.02.001 · Cited by 185
Neoadjuvant chemotherapy prior to radical cystectomy for muscle‐invasive bladder cancer with variant histology
Vetterlein, M. W., Wankowicz, S. A. M., Seisen, T., Lander, R., Löppenberg, B., Chun, F. K. ‐., Menon, M., Sun, M., Barletta, J. A., Choueiri, T. K., et al. (2017) · Cancer · doi:10.1002/cncr.30907 · Cited by 186
Molecular characterization of breast cancer CTCs associated with brain metastasis
Boral, D., Vishnoi, M., Liu, H. N., Yin, W., Sprouse, M. L., Scamardo, A. T., Hong, D. S., Tan, T. Z., Thiery, J. P., Chang, J. C., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00196-1 · Cited by 191
Exosomal Metastasis‑Associated Lung Adenocarcinoma Transcript 1 Promotes Angiogenesis and Predicts Poor Prognosis in Epithelial Ovarian Cancer
Qiu, J., Lin, X., Tang, X.-Y., Zheng, T.-T., Lin, Y., & Hua, K. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.28048 · Cited by 188
Nanoparticle-based drug delivery via RBC-hitchhiking for the inhibition of lung metastases growth
Zelepukin, I. V., Yaremenko, A. V., Shipunova, V. O., Babenyshev, A., Balalaeva, I. V., Nikitin, P. I., Deyev, S. M., & Nikitin, M. P. (2018) · Nanoscale · doi:10.1039/c8nr07730d · Cited by 189
DNA biosensors based on gold nanoparticles-modified graphene oxide for the detection of breast cancer biomarkers for early diagnosis
Saeed, A. A., Sánchez, J. L. A., O’Sullivan, C. K., & Abbas, M. N. (2017) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2017.07.002 · Cited by 190
Precision Cancer Nanotherapy: Evolving Role of Multifunctional Nanoparticles for Cancer Active Targeting
Ahmad, A., Khan, F., Mishra, R. K., & Khan, R. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00511 · Cited by 192
State of the science on prevention and screening to reduce melanoma incidence and mortality: The time is now
Tripp, M. K., Watson, M., Balk, S. J., Swetter, S. M., & Gershenwald, J. E. (2016) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21352 · Cited by 191
Oral Cavity Cancer
Ettinger, K. S., Ganry, L., & Fernandes, R. (2018) · Oral and Maxillofacial Surgery Clinics of North America · doi:10.1016/j.coms.2018.08.002 · Cited by 184
U.S. FDA Approval Summary: Nivolumab for Treatment of Unresectable or Metastatic Melanoma Following Progression on Ipilimumab
Hazarika, M., Chuk, M. K., Theoret, M. R., Mushti, S. L., He, K., Weis, S. L., Putman, A. H., Helms, W. S., Cao, X., Li, H., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0712 · Cited by 184
Development of an automated wax-printed paper-based lateral flow device for alpha-fetoprotein enzyme-linked immunosorbent assay
Preechakasedkit, P., Siangproh, W., Khongchareonporn, N., Ngamrojanavanich, N., & Chailapakul, O. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.10.051 · Cited by 184
Cancer Diagnosis in Patients with Heart Failure: Epidemiology, Clinical Implications and Gaps in Knowledge
Ameri, P., Canepa, M., Anker, M. S., Belenkov, Y. N., Bergler-Klein, J. K., Solal, A. C., Farmakis, D. T., López‐Fernández, T., Lainščak, M., Pudil, R., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1165 · Cited by 184
Potential Therapeutic Targets of Quercetin, a Plant Flavonol, and Its Role in the Therapy of Various Types of Cancer through the Modulation of Various Cell Signaling Pathways
Almatroodi, S. A., Alsahli, M. A., Almatroudi, A., Verma, A. K., Aloliqi, A. A., Allemailem, K. S., Khan, A. A., & Rahmani, A. H. (2021) · Molecules · doi:10.3390/molecules26051315 · Cited by 194
Acute radiation dermatitis in breast cancer patients: challenges and solutions
Kole, A. J., Kole, L. C. S., & Moran, M. S. (2017) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s109763 · Cited by 183
Global burden of cutaneous melanoma attributable to ultraviolet radiation in 2012
Arnold, M., de Vries, E., Whiteman, D. C., Jemal, A., Bray, F., Parkin, D. M., & Soerjomataram, I. (2018) · International Journal of Cancer · doi:10.1002/ijc.31527 · Cited by 194
Self-citation
Survivorship Care Plans in Cancer: A Meta-Analysis and Systematic Review of Care Plan Outcomes
Hill, R., Wakefield, C. E., Cohn, R. J., Fardell, J. E., Brierley, M., Kothe, E. J., Jacobsen, P. B., Hetherington, K., & Mercieca‐Bebber, R. (2019) · The Oncologist · doi:10.1634/theoncologist.2019-0184 · Cited by 186
A comprehensive analysis of breast cancer microbiota and host gene expression
Thompson, K. J., Ingle, J. N., Tang, X., Chia, N., Jeraldo, P. R., Walther-Antonio, M. R., Kandimalla, K. K., Johnson, S., Yao, J. Z., Harrington, S. C., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0188873 · Cited by 183
Noninvasive ovarian cancer biomarker detection via an optical nanosensor implant
Williams, R. M., Lee, C., Galassi, T. V., Harvey, J. D., Leicher, R., Sirenko, M., Dorso, M. A., Shah, J., Olvera, N., Dao, F., et al. (2018) · Science Advances · doi:10.1126/sciadv.aaq1090 · Cited by 183
Proportion of Never-Smoker Non–Small Cell Lung Cancer Patients at Three Diverse Institutions
Pelosof, L. C., Ahn, C. W., Gao, A., Horn, L., Madrigales, A., Cox, J., McGavic, D., Minna, J. D., Gazdar, A. F., & Schiller, J. H. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw295 · Cited by 184
Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer
Li, C., Wan, L., Liu, Z., Xu, G., Wang, S., Su, Z., Zhang, Y., Zhang, C., Liu, X., Lei, Z., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.036 · Cited by 181
Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell
Gao, J., Xu, W., Liu, W., Yan, M., & Zhu, Z. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i24.2567 · Cited by 180
LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR‐128/CD151 pathway in hepatocellular carcinoma
Zhang, P., Wang, F., Wu, J., Wu, Y., Huang, W., Liu, D., Huang, X., Zhang, X., & Ke, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27095 · Cited by 181
Deep Learning-Based Framework for In Vivo Identification of Glioblastoma Tumor using Hyperspectral Images of Human Brain
Fabelo, H. A., Halicek, M. T., Ortega, S., Shahedi, M., Szołna, A., Piñeiro, J. F., Sosa, C., Jiménez-O’Shanahan, A., Bisshopp, S., Espino, C., et al. (2019) · Sensors · doi:10.3390/s19040920 · Cited by 187
Exosomes as Drug Carriers for Cancer Therapy
Pullan, J. E., Confeld, M. I., Osborn, J., Kim, J., Sarkar, K., & Mallik, S. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00104 · Cited by 179
A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer
Fantini, D., Glaser, A. P., Rimar, K. J., Wang, Y., Schipma, M. J., Varghese, N., RADEMAKER, A. W., Behdad, A., Yellapa, A., Yu, Y., et al. (2018) · Oncogene · doi:10.1038/s41388-017-0099-6 · Cited by 179
CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression
Yu, J., Liu, D., Sun, X., Yang, K., Yao, J., Chen, C., Wang, C., & Zheng, J. (2019) · Cell Death and Disease · doi:10.1038/s41419-018-1263-9 · Cited by 180
Curcumin-Encapsulated Polymeric Micelles Suppress the Development of Colon Cancer In Vitro and In Vivo
Yang, X., Li, Z., Wang, N., Li, L., Song, L., He, T., Sun, L., Wang, Z., Wu, Q., Luo, N., et al. (2015) · Scientific Reports · doi:10.1038/srep10322 · Cited by 179
KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment
Zeitouni, D., Pylayeva‐Gupta, Y., Der, C. J., & Bryant, K. L. (2016) · Cancers · doi:10.3390/cancers8040045 · Cited by 191
Lung cancer-associated brain metastasis: Molecular mechanisms and therapeutic options
Yousefi, M., Bahrami, T., Salmaninejad, A., Nosrati, R., Ghaffari, P., & Ghaffari, S. H. (2017) · Cellular Oncology · doi:10.1007/s13402-017-0345-5 · Cited by 180
A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer
Mello, S. S., Valente, L. J., Raj, N., Seoane, J. A., Flowers, B. M., McClendon, J., Bieging-Rolett, K. T., Lee, J., Ivanochko, D., Kozak, M. M., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.09.007 · Cited by 179
Tumor Microenvironment Heterogeneity: Challenges and Opportunities
Runa, F., Hamalian, S., Meade, K., Shisgal, P., Gray, P. C., & Kelber, J. A. (2017) · Current Molecular Biology Reports · doi:10.1007/s40610-017-0073-7 · Cited by 183
Colorectal Cancer Disparity in African Americans
Augustus, G. J., & Ellis, N. A. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.07.023 · Cited by 186
Increasing Rates of Surgery for Patients With Nonmalignant Colorectal Polyps in the United States
Peery, A. F., Cools, K. S., Strassle, P. D., McGill, S., Crockett, S. D., Barker, A., Koruda, M. J., & Grimm, I. S. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.01.003 · Cited by 179
Illuminating the Anticancerous Efficacy of a New Fungal Chassis for Silver Nanoparticle Synthesis
Aziz, N., Faraz, M., Sherwani, M. A., Fatma, T., & Prasad, R. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00065 · Cited by 179
CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis
Su, H., Ruan, J., Chen, T., Lin, E., & Shi, L. (2019) · Cancer Imaging · doi:10.1186/s40644-019-0270-0 · Cited by 184
Lung Nodule Detection based on Faster R-CNN Framework
Su, Y., Li, D., & Chen, X. (2020) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2020.105866 · Cited by 179
Long noncoding RNAs as promising biomarkers in cancer
Beylerli, O., Фанилевич, Г. И., Sufianov, A. A., Ilyasova, T., & Guang, Y. (2022) · Non-coding RNA Research · doi:10.1016/j.ncrna.2022.02.004 · Cited by 179
Targeting Epidermal Growth Factor Receptor in triple negative breast cancer: New discoveries and practical insights for drug development
Costa, R. L. B., Shah, A. N., Santa-Maria, C. A., Cruz, M. R. D. S., Mahalingam, D., Carneiro, B. A., Chae, Y. K., Cristofanilli, M., Gradishar, W. J., & Giles, F. J. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.12.010 · Cited by 177
Hypoxia-induced autophagy drives colorectal cancer initiation and progression by activating the PRKC/PKC-EZR (ezrin) pathway
Qureshi-Baig, K., Kuhn, D., Viry, E., Pozdeev, V. I., Schmitz, M., Rodriguez, F., Ullmann, P., Koncina, E., Nurmik, M., Frasquilho, S., et al. (2019) · Autophagy · doi:10.1080/15548627.2019.1687213 · Cited by 178
Human papilloma virus: Apprehending the link with carcinogenesis and unveiling new research avenues (Review)
Boda, D., Docea, A. O., Călina, D. C., Ilie, M. A., Căruntu, C., Zurac, S., Neagu, M. T., Constantin, C., Branisteanu, D. E., Voiculescu, V. M., et al. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4256 · Cited by 177
An Expression Signature as an Aid to the Histologic Classification of Non–Small Cell Lung Cancer
Girard, L., Rodriguez-Canales, J., Behrens, C., Thompson, D. M., Botros, I. W., Tang, H., Xie, Y., Rekhtman, N., Travis, W. D., Wistuba, I. I., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2900 · Cited by 154
miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1
Liu, Y., Liu, R., Yang, F., Cheng, R., Chen, X., Cui, S., Gu, Y., Sun, W., You, C., 刘志坚, et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0625-8 · Cited by 178
Hierarchical Convolutional Neural Networks for Segmentation of Breast Tumors in MRI With Application to Radiogenomics
Zhang, J., Saha, A., Zhu, Z., & Mazurowski, M. A. (2018) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2018.2865671 · Cited by 175
Inconsistent Performance of Deep Learning Models on Mammogram Classification
Wang, X., Liang, G., Zhang, Y., Blanton, H., Bessinger, Z., & Jacobs, N. (2020) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2020.01.006 · Cited by 181
Pancreatic cancer: Stroma and its current and emerging targeted therapies
Kota, J., Hancock, J., Kwon, J. J., & Korc, M. (2017) · Cancer Letters · doi:10.1016/j.canlet.2016.12.035 · Cited by 177
Emerging Roles of Electrospun Nanofibers in Cancer Research
Chen, S., Boda, S. K., Batra, S. K., Li, X., & Xie, J. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201701024 · Cited by 177
Chemotherapy and targeted therapy in the management of cervical cancer
Kumar, L., Harish, P., Malik, P. S., & Khurana, S. (2018) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2018.01.016 · Cited by 175
Predicting Treatment Response to Intra-arterial Therapies for Hepatocellular Carcinoma with the Use of Supervised Machine Learning—An Artificial Intelligence Concept
Abajian, A. C., Murali, N., Savic, L. J., Gaupp, F. M. L., Nezami, N., Duncan, J. S., Schlachter, T. R., Lin, M., Geschwind, J.-F., & Chapiro, J. (2018) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2018.01.769 · Cited by 175
Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4(3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers
Mahdy, H. A., Ibrahim, M. K., Metwaly, A. M., Belal, A., Mehany, A. B. M., El‐Gamal, K. M., El-Sharkawy, A., Elhendawy, M. A., Radwan, M. M., ElSohly, M. A., et al. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103422 · Cited by 177
Classification of Skin Lesions into Seven Classes Using Transfer Learning with AlexNet
Hosny, K. M., Kassem, M. A. A., & Fouad, M. M. (2020) · Journal of Imaging Informatics in Medicine · doi:10.1007/s10278-020-00371-9 · Cited by 181
METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N6-methyladenosine-dependent YTHDF binding
Wang, W., Shao, F., Yang, X., Wang, J., Zhu, R., Yang, Y., Zhao, G., Guo, D. S., Sun, Y., Wang, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23501-5 · Cited by 174
Risk factors of Lung Cancer in nonsmoker
Akhtar, N., & Gupta, J. (2017) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2017.07.002 · Cited by 185
Early-onset Colorectal Cancer is Distinct From Traditional Colorectal Cancer
Yeo, H., Betel, D., Abelson, J. S., Zheng, X., Yantiss, R. K., & Shah, M. A. (2017) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2017.06.002 · Cited by 175
Cancer-associated Fibroblast-derived IL-6 Promotes Head and Neck Cancer Progression via the Osteopontin-NF-kappa B Signaling Pathway
Qin, X., Yan, M., Wang, X., Xu, Q., Wang, X., Zhu, X., Shi, J., Li, Z., Zhang, J., & Chen, W. (2018) · Theranostics · doi:10.7150/thno.22182 · Cited by 176
Pixels to Classes: Intelligent Learning Framework for Multiclass Skin Lesion Localization and Classification
Khan, M. A., Zhang, Y., Sharif, M., & Akram, T. (2021) · Computers & Electrical Engineering · doi:10.1016/j.compeleceng.2020.106956 · Cited by 173
Carcinogenesis mechanisms of Fusobacterium nucleatum
Gholizadeh, P., Eslami, H., & Kafil, H. S. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.02.102 · Cited by 175
Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy
Sleightholm, R. L., Neilsen, B. K., Li, J., Steele, M. M., Singh, R. K., Hollingsworth, M. A., & Oupický, D. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.05.012 · Cited by 171
Carotenoid Lutein Selectively Inhibits Breast Cancer Cell Growth and Potentiates the Effect of Chemotherapeutic Agents through ROS-Mediated Mechanisms
Gong, X., Smith, J., Swanson, H., & Rubin, L. P. (2018) · Molecules · doi:10.3390/molecules23040905 · Cited by 171

Authors: Siegel, R. L., Miller, K. D., & Jemal, A.
Affiliations: American Cancer Society (US)
Corresponding author: Siegel, Rebecca L.
ORCID: Siegel, Rebecca L.
Miller, Kimberly D.
Jemal, Ahmedin
Venue: CA: A Cancer Journal for Clinicians
Publisher: Wiley
Published: 2016-01
Volume: 66
Issue: 1
Pages: 7-30
ISSN: 0007-9235 (ISSN-L)
1542-4863
DOI: 10.3322/caac.21332
OpenAlex: W2235523093
Cited by: 16,003
References: 66
Citations by year: 2026: 50 · 2025: 222 · 2024: 343 · 2023: 563 · 2022: 795 · 2021: 1226 · 2020: 1590 · 2019: 2001 · 2018: 3108 · 2017: 4325 · 2016: 1700
FWCI: 2000.05
Type: journal article
Language: en
Open access: gold
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 6 d)
Locations: CA A Cancer Journal for Clinicians (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Science, Research, and Medicine
Keywords: cancer incidence, cancer mortality, cancer survival, cancer projections, incidence trends, prostate cancer, liver cancer, pancreatic cancer, endometrial cancer, brain cancer, childhood cancer, cancer control, cancer research funding
MeSH terms: American Cancer Society, Female, Humans, Male, Neoplasms, Registries, United States, Incidence, Survival Rate, Sex Distribution, SEER Program, Racial Groups

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cancer statistics, 2016

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks